Kyverna to present stiff person syndrome trial data at AAN 2026
Tweet Send to a Friend
Kyverna Therapeutics Inc. (NASDAQ: KYTX) will present data from multiple studies at the American Academy of Neurology Annual Meeting in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


